Physician–patient communication about dietary supplements

Tarn, Derjung M.; Paterniti, Debora A.; Good, Jeffrey S.; Coulter, Ian D.; Galliher, James M.; Kravitz, Richard L.; Karlamangla, Arun S.; Wenger, Neil S.

doi:10.1016/j.pec.2013.01.021

Cited by 39 publications

(32 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may well reflect a general sense on the part of both clinicians and patients that for medications to be available over the counter, there is an intrinsic degree of safety that allows a more relaxed or minimized approach in discussing risks and side effects. This result is similar to research findings that discussions about dietary supplements are suboptimal regarding risk [39].…”

Section: Discussionsupporting

confidence: 90%

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

Childress

Ledford

Mundy

2014

Patient Education and Counseling

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 90%

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

Childress

Ledford

Mundy

2014

Patient Education and Counseling

View full text Add to dashboard Cite

“…Previous studies have noted that underreport of dietary supplements use is common among patients 50 and that physician-patient communication is infrequent regarding efficacy and adverse effects of dietary supplements. 51 …”

Section: Discussionmentioning

confidence: 99%

Longitudinal Use of Complementary and Alternative Medicine Among Older Adults With Radiographic Knee Osteoarthritis

Yang

Dubé

Eaton

et al. 2013

Clinical Therapeutics

View full text Add to dashboard Cite

Background Osteoarthritis (OA) accounts for more mobility issues in older adults than any other disease. OA is a chronic and often painful disease for which there is no cure. Cross-sectional studies have shown that older adults frequently use complementary and alternative medicine (CAM) and arthritis is the most common reason for CAM use. While previous research has profiled the sociodemographic and clinical characteristics of CAM users, few have provided information on variation in CAM use over time and most only considered use of any CAM, which was often a mixture of heterogeneous therapies. Objectives This study sought to describe the longitudinal patterns of CAM use among older adults with knee OA, and to identify correlates/predictors of different commonly-used CAM therapies. Methods The Osteoarthritis Initiative included 1,121 adults aged 65 years and above with radiographic tibiofemoral OA in one or both knees at baseline. Annual surveys captured current use of conventional therapies and 25 CAM modalities (grouped into 6 categories) for joint pain or arthritis at baseline and during the 4-year follow-up. We assessed longitudinal use of CAM modalities by summing the number of visits with participants reporting use of each modality. Correlates of CAM use under consideration included sociodemographic indicators, body mass index, overall measures of mental and physical wellbeing, and clinical indices of knee OA. Generalized estimation equations provided adjusted odds ratio estimates and 95% confidence intervals. Results Nearly one third of older adults reported using ≥ one CAM modality for treating OA at all assessments. With the exception of glucosamine and chondroitin (18%), few were persistent users of other CAM modalities. One in five of those using NSAIDs or glucosamine/chondroitin were using them concurrently. Adjusted models showed: 1) adults aged ≥75 years were less likely to use dietary supplements than those aged between 65 and 75 years; 2) persons with more severe knee pain or stiffness reported more CAM use; 3) better knee-related physical function was correlated with more use of chiropractic/massage; 4) older adults with more comorbidities were less likely to report use of dietary supplements. Conclusion Patterns of CAM use are, to some extent, inconsistent with current guidelines for OA treatment. Evaluating the potential risks and benefits in older adults from commonly-used CAM modalities, with or without combination use of conventional analgesics, is warranted.

show abstract

“…Preservation of bone volume after tooth loss increases quality of life 1 and allows multiple choices of dental rehabilitation after tooth loss. 2 Loss of alveolar bone volume after tooth extraction remains a challenge in oral surgery, 3 both after tooth extraction and after loss of jaw bone due to tumor lesions in the jaw.…”

Section: Introductionmentioning

confidence: 99%

Complication Rate of Osteoconductive Membranes Over Fresh Alveolar Sockets

Pohodenko-Chudakova¹,

Tserkhava²,

Maksimovich³

et al. 2017

EDUJ

View full text Add to dashboard Cite

Cite this article:Pohodenko-Chudakova I, Tserakhava T, Maksimovich K, Zenkevich Y. Complication rate of osteoconductive membranes over fresh alveolar sockets. Stoma Edu J. 2017;4(3):171-174. Introduction:The aim of the study was to assess the clinical efficacy of the osteoconductive bioresorbable membranes "Collapan" and "Collost" used for the preservation of the alveolar process and to compare it with the natural bone healing of an alveolar socket. Materials and methods: The 67 patients observed were divided into 3 groups. The first group included 20 individuals who were treated by covering the alveolus with the "Collapan" membrane. Group 2 included 22 patients in whom the "Collost" membrane was used. The third group (control) consisted of 25 patients in whom the alveolus was not covered with any membrane over the natural blood clot. The clinical efficacy of the membranes was based on the number of complications in the postoperative period. Also, the level of alveolar bone reduction was measured using residual height and width as parameters. Results: In the postoperative period, 6 (9%) complications of an infectious-inflammatory nature were detected in group 1, 2 (3%) -in group 2, 19 (28%) -in group 3. The use of the "Collost" yielded the best result in preserving alveolar height and width. Conclusion:The results of this pilot study showed that it is appropriate to use the osteoplastic bioresorbable "Collost" and "Collapan" membranes due to the low incidence of complications and the favourable effect on preserving bone volume.

show abstract

Physician–patient communication about dietary supplements

Cited by 39 publications

References 24 publications

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

Longitudinal Use of Complementary and Alternative Medicine Among Older Adults With Radiographic Knee Osteoarthritis

Complication Rate of Osteoconductive Membranes Over Fresh Alveolar Sockets

Contact Info

Product

Resources

About